Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program
Sponsor: Axio Research. LLC
This PHASE1 trial investigates Healthy and is currently completed. Axio Research. LLC leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE1
-
Jan 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Aug 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE1
-
Sep 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE1
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Enrolling By Invitation PHASE1
-
Apr 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE1
Status: Not Yet Recruiting → Enrolling By Invitation
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Axio Research. LLC
- Biomat USA, Inc.
- Hammond Clinical Trial Consulting, LLC
For direct contact, visit the study record on ClinicalTrials.gov .